APPLICATION
ANDA077061
TYPE
ANDA
ORIGINAL APPROVAL
2005-03-28
LATEST ACTION
2025-12-10
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription
Products
MOMETASONE FUROATEPrescription
MOMETASONE FUROATE 0.1% · OINTMENT · TOPICAL
Approval history
2025-12-10Labeling · Supplement 6 · standardAP
2015-10-31Labeling · Supplement 3 · standardAP
2005-03-28OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.